JP2012510803A5 - - Google Patents

Download PDF

Info

Publication number
JP2012510803A5
JP2012510803A5 JP2011539034A JP2011539034A JP2012510803A5 JP 2012510803 A5 JP2012510803 A5 JP 2012510803A5 JP 2011539034 A JP2011539034 A JP 2011539034A JP 2011539034 A JP2011539034 A JP 2011539034A JP 2012510803 A5 JP2012510803 A5 JP 2012510803A5
Authority
JP
Japan
Prior art keywords
isolated
isolated peptide
nucleic acid
protease
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011539034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012510803A (ja
JP5840498B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/066395 external-priority patent/WO2010063818A2/en
Publication of JP2012510803A publication Critical patent/JP2012510803A/ja
Publication of JP2012510803A5 publication Critical patent/JP2012510803A5/ja
Application granted granted Critical
Publication of JP5840498B2 publication Critical patent/JP5840498B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011539034A 2008-12-05 2009-12-04 プロテアーゼ耐性ポリペプチドを選択するための方法 Active JP5840498B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12013508P 2008-12-05 2008-12-05
US61/120,135 2008-12-05
PCT/EP2009/066395 WO2010063818A2 (en) 2008-12-05 2009-12-04 Methods for selecting protease resistant polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015147120A Division JP2015231380A (ja) 2008-12-05 2015-07-24 プロテアーゼ耐性ポリペプチドを選択するための方法

Publications (3)

Publication Number Publication Date
JP2012510803A JP2012510803A (ja) 2012-05-17
JP2012510803A5 true JP2012510803A5 (cg-RX-API-DMAC7.html) 2013-01-31
JP5840498B2 JP5840498B2 (ja) 2016-01-06

Family

ID=42169477

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011539034A Active JP5840498B2 (ja) 2008-12-05 2009-12-04 プロテアーゼ耐性ポリペプチドを選択するための方法
JP2015147120A Pending JP2015231380A (ja) 2008-12-05 2015-07-24 プロテアーゼ耐性ポリペプチドを選択するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015147120A Pending JP2015231380A (ja) 2008-12-05 2015-07-24 プロテアーゼ耐性ポリペプチドを選択するための方法

Country Status (15)

Country Link
US (3) US8685895B2 (cg-RX-API-DMAC7.html)
EP (1) EP2364326B1 (cg-RX-API-DMAC7.html)
JP (2) JP5840498B2 (cg-RX-API-DMAC7.html)
KR (1) KR101740066B1 (cg-RX-API-DMAC7.html)
CN (1) CN102307897B (cg-RX-API-DMAC7.html)
AU (1) AU2009324037B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0922772B1 (cg-RX-API-DMAC7.html)
CA (1) CA2745448C (cg-RX-API-DMAC7.html)
EA (1) EA026508B1 (cg-RX-API-DMAC7.html)
ES (1) ES2688621T3 (cg-RX-API-DMAC7.html)
IL (1) IL212923A0 (cg-RX-API-DMAC7.html)
MX (1) MX2011005874A (cg-RX-API-DMAC7.html)
SG (1) SG194383A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010063818A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201103575B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2364326B1 (en) * 2008-12-05 2018-07-04 Glaxo Group Limited Methods for selecting protease resistant polypeptides
WO2012020143A1 (en) * 2010-08-13 2012-02-16 Glaxo Group Limited Improved anti-serum albumin binding variants
EP2606065A2 (en) * 2010-08-20 2013-06-26 GlaxoSmithKline Intellectual Property Development Limited Improved anti-serum albumin binding variants
EP2866029B1 (en) * 2012-06-22 2017-05-03 Olympus Corporation Method for preparing sample containing pancreatic juice component, and kit for storing biological sample containing pancreatic juice component at room temperature
CA2918221A1 (en) * 2013-07-15 2015-01-22 North Carolina State University Protease-resistant peptide ligands
PL3039038T3 (pl) * 2013-08-30 2021-04-19 Aprilbio Co., Ltd Konstrukt fuzyjny z fab przeciwko albuminie surowicy i ugrupowania efektorowego oraz sposób jego przygotowania
US10294306B2 (en) * 2015-05-28 2019-05-21 Bio-Rad Laboratories, Inc. Affinity ligands and methods relating thereto
TWI726889B (zh) * 2015-06-10 2021-05-11 英商梅迪繆思有限公司 蛋白酶抗性之脂化肽
JP6766253B2 (ja) * 2017-03-28 2020-10-07 森永乳業株式会社 新規ビフィドバクテリウム属細菌
WO2020176678A1 (en) * 2019-02-26 2020-09-03 Twist Bioscience Corporation Variant nucleic acid libraries for glp1 receptor
US11584781B2 (en) * 2019-12-30 2023-02-21 Eligo Bioscience Chimeric receptor binding proteins resistant to proteolytic degradation
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물
AU2021331088A1 (en) 2020-08-26 2023-05-04 Twist Bioscience Corporation Methods and compositions relating to glp1r variants
US12122817B2 (en) * 2020-09-22 2024-10-22 Serpentide Inc. Long-lasting GLP1 analogue drug for type-2 diabetes

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8725529D0 (en) 1987-10-30 1987-12-02 Delta Biotechnology Ltd Polypeptides
JP3095168B2 (ja) 1988-02-05 2000-10-03 エル. モリソン,シェリー ドメイン‐変性不変部を有する抗体
DE68927933T2 (de) 1988-09-02 1997-08-14 Dyax Corp Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
ATE92107T1 (de) 1989-04-29 1993-08-15 Delta Biotechnology Ltd N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5977307A (en) 1989-09-07 1999-11-02 Alkermes, Inc. Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
AU8507191A (en) 1990-08-29 1992-03-30 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
EP1046421B8 (en) 1990-12-06 2006-01-11 Affymetrix, Inc. (a Delaware Corporation) Methods and reagents for very large scale immobilized polymer synthesis
WO1993011236A1 (en) 1991-12-02 1993-06-10 Medical Research Council Production of anti-self antibodies from antibody segment repertoires and displayed on phage
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
CA2163345A1 (en) 1993-06-16 1994-12-22 Susan Adrienne Morgan Antibodies
US5702892A (en) 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
EP1019496B1 (en) 1997-07-07 2004-09-29 Medical Research Council In vitro sorting method
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
GB2361237A (en) 1998-05-13 2001-10-17 Diversys Ltd Selection system
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
GB2375112A (en) 2000-02-03 2002-11-06 Domantis Ltd Combinatorial protein domains
DK1355942T3 (da) 2000-12-07 2008-11-17 Lilly Co Eli GLP-1-fusionsproteiner
WO2002095076A2 (en) 2001-05-23 2002-11-28 Kabushiki Kaisha Toyota Chuo Kenkyusho Modified polypeptides having protease-resistance and/or protease-sensitivity
DE60224284T2 (de) 2001-06-28 2008-12-18 Novo Nordisk A/S Stabile formulierung von modifiziertem glp-1
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
US20080108560A1 (en) 2002-03-05 2008-05-08 Eli Lilly And Company Heterologous G-Csf Fusion Proteins
US7696320B2 (en) * 2004-08-24 2010-04-13 Domantis Limited Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
US20060002935A1 (en) 2002-06-28 2006-01-05 Domantis Limited Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
CA2505326A1 (en) 2002-11-08 2004-05-21 Ablynx N.V. Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
JP4949838B2 (ja) 2003-09-19 2012-06-13 ノヴォ ノルディスク アー/エス 新規glp−1誘導体
DK1737962T3 (da) 2004-03-24 2010-12-13 Domantis Ltd GAS1-universel leder
SG157423A1 (en) * 2004-12-02 2009-12-29 Domantis Ltd Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
US8841413B2 (en) * 2006-10-03 2014-09-23 Cadila Healthcare Limited Antidiabetic compounds
GB0724331D0 (en) * 2007-12-13 2008-01-23 Domantis Ltd Compositions for pulmonary delivery
MX2010010776A (es) * 2008-03-31 2010-10-26 Glaxo Group Ltd Fusiones y conjugados de farmaco.
EP2364326B1 (en) * 2008-12-05 2018-07-04 Glaxo Group Limited Methods for selecting protease resistant polypeptides
ES2654929T3 (es) * 2009-02-19 2018-02-15 Glaxo Group Limited Variantes de unión de anti-albúmina de suero mejoradas

Similar Documents

Publication Publication Date Title
JP2012510803A5 (cg-RX-API-DMAC7.html)
JP2023179436A5 (cg-RX-API-DMAC7.html)
US20130040877A1 (en) Long-acting y2 receptor agonists
NZ596778A (en) Glucose-regulating polypeptides and methods of making and using same
NZ597685A (en) Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
JP2010529860A5 (cg-RX-API-DMAC7.html)
JP2014510518A5 (cg-RX-API-DMAC7.html)
JP2013545724A5 (cg-RX-API-DMAC7.html)
JP2007513634A5 (cg-RX-API-DMAC7.html)
JP2010529849A (ja) グルカゴン類似体
JP2016512213A5 (cg-RX-API-DMAC7.html)
EA200901108A1 (ru) Соагонисты глюкагоновых/glp-1-рецепторов
JP2016512213A (ja) 肥満の治療のためのペグ化グルカゴン及びglp−1コアゴニスト
US20210221866A1 (en) Protease-resistant lipidated glp-1 analogs
JP2015504052A5 (cg-RX-API-DMAC7.html)
MX2008009493A (es) Peptido novedoso y uso del mismo.
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
EP4476248A1 (en) Glp-1 and glucagon dual agonist peptides with improved biological stability
CY1111630T1 (el) Παραγωγα κυτοκινων
KR20190017017A (ko) 프로테아제-내성 모노-지질화된 펩타이드
WO2006111946A3 (en) Toll-like receptor 14 (tlr14 ) and use thereof
JP2020511425A5 (cg-RX-API-DMAC7.html)
JP2008517998A5 (cg-RX-API-DMAC7.html)
WO2007064844A3 (en) Anti-viral griffithsin compounds, compositions, and methods of use
CN120530127A (zh) 新型三重glp-1/gip/胰高血糖素受体激动剂及包括其的用于预防或治疗肥胖症的药物组合物